EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients

Tongtong Wang iD, Chuanying Geng, Guangzhong Yang, Huixing Zhou, Zhiyao Zhang, Yuan Jian, Wenming Chen

Journal of Clinical Laboratory Analysis · 2024

DOI: 10.1002/jcla.25072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2024. Verfasst von Tongtong Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Chromosomes, Human, Pair 1, Chromosome Aberrations. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chromosome 1q21 aberrations are one of the most common cytogenetic abnormalities in patients with multiple myeloma (MM). However, the prognostic value remains controversial. This study aimed to determine the prognostic value of numerical abnormalities of chromosome 1q21 for newly diagnosed patients with MM patients in Chinese population.

Methods

We retrospectively analyzed 629 patients with newly diagnosed MM who received the detection of chromosome 1q21 by fluorescence in situ hybridization in China.

Results

Among 629 patients, 309 (49.1%) had 1q21 abnormalities, of which 187 (29.7%) had three copies and 122 (19.4%) had four or more copies. Patients with two copies of 1q21 had a significantly longer median overall survival (OS) than those with three copies or ≥4 copies and also had longer progression‐free survival (PFS). However, patients with three or ≥4 copies had similar OS and PFS. Univariate Cox proportional hazards regression analyses determined that 1q21 aberrations are associated with shorter OS and PFS. 1q21 aberrations are also independent poor prognostic factors for OS and PFS in multivariable analyses. Del(17p), t(4;14), and t(14;16) are common high‐risk cytogenetic abnormalities (HRCAs) in patients with MM. Patients with 1q21+ alone or 1q21+ combined with HRCAs had shorter OS and PFS than patients without cytogenetic abnormalities. Patients with 1q21+ and t(11;14) also had shorter PFS but had similar OS than patients without cytogenetic abnormalities.

Conclusion

Our study showed that chromosome 1q21 aberrations are poor prognostic factors for newly diagnosed patients with MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaChromosomes, Human, Pair 1Chromosome AberrationsHumansMaleFemaleMiddle AgedAgedPrognosisAdultRetrospective StudiesAged, 80 and overIn Situ Hybridization, Fluorescence

Stichwörter der Autor:innen

1q21 aberrationschromosomal aberrationsmultiple myelomaprognostic factorsurvival

Autor:innen und Institutionen

  • Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Tongtong Wang

Zitieren

APA

Wang, T., Geng, C., Yang, G., Zhou, H., Zhang, Z., Jian, Y., & Chen, W. (2024). Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.25072

Vancouver

Wang T, Geng C, Yang G, Zhou H, Zhang Z, Jian Y, et al. Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients. Journal of Clinical Laboratory Analysis. 2024. doi:10.1002/jcla.25072

BibTeX
@article{Wang2024,
  author = {Wang, Tongtong and Geng, Chuanying and Yang, Guangzhong and Zhou, Huixing and Zhang, Zhiyao and Jian, Yuan and Chen, Wenming},
  title = {Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2024},
  doi = {10.1002/jcla.25072}
}
Kostenlos starten →